Loading...
Chemical structure of SARS-CoV-2 nsp13-IN-1

GC69861

SARS-CoV-2 nsp13-IN-1

Also known as N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide

SARS-CoV-2 nsp13-IN-1 (compound C1) is an effective inhibitor of nsp13 (non-structural protein 13)· SARS-CoV-2 nsp13-IN-1 only inhibits the ssDNA+ ATPase activity of nsp13, with an IC50 of 6 μM· It does not inhibit ssDNA- ATPase activity· SARS-CoV-2 nsp13-IN-1 can be used for COVID-19 research

ChemicalCAS1005304-44-8MW432.47FormulaC27H20N4O2
CAS number
1005304-44-8
Molecular weight
432.47
Formula
C27H20N4O2
Solubility
DMSO ： 41·67 mg/mL (96·35 mM; ultrasonic and warming and heat to 60°C)
InChIKey
YQMFYRIEVDLXHD-UHFFFAOYSA-N
Catalogue number
GC69861
Brand
GLPBIO
Computed properties PubChem CID 18569226 · XLogP 4.2 · TPSA 74.7 Ų · H-bond donors 1
XLogP
4.2
TPSA
74.7 Ų
H-bond donors
1
H-bond acceptors
4
Rotatable bonds
4
Heavy atoms
33

SMILES CC1=NC2=C(C=CC=N2)C(=O)N1C3=CC=C(C=C3)NC(=O)C4=CC=C(C=C4)C5=CC=CC=C5

Computed descriptors from PubChem (CID 18569226), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.